Ceresnie, Marissa S.
Warbasse, Elizabeth
Gonzalez, Sarah
Pourang, Aunna
Hamzavi, Iltefat H.
Article History
Received: 3 February 2023
Revised: 3 February 2023
Accepted: 14 March 2023
First Online: 7 April 2023
Declarations
:
: MSC is a sub-investigator for Avita Medical, Incyte Corporation, Clinuvel Pharmaceuticals, and the Immune Tolerance Network. IHH helped develop the vitiligo area scoring index and has served as an advisory board member for AbbVie; a consultant for Incyte Corporation, Pfizer, and UCB; a principal investigator for AbbVie, Allergan, Avita Medical, Bayer, Clinuvel Pharmaceuticals, Estée Lauder, Ferndale Laboratories, Galderma Laboratories LP, GE Healthcare, Incyte Corporation, Janssen, Janssen Biotech, Johnson & Johnson, Lenicura, LEO Pharma, Pfizer, The Immune Tolerance Network, and Unigen; a sub-investigator for Amgen, Bristol Myers Squibb, Foamix Pharmaceuticals, and Janssen; past-president of the Hidradenitis Suppurativa Foundation; and co-chair of the Global Vitiligo Foundation.
: This is a scoping review and does not include information or images which could identify or potentially identify individuals.